Beijing, China

Tianyang Liu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: China-Japan Friendship Hospital (China-Japan Friendship Clinical Medical Research Institute). Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Tianyang Liu in Microfluidic Bone Organoid Technology

Introduction

Tianyang Liu is an innovative inventor based in Beijing, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of microfluidic technologies. His work focuses on creating advanced methods for studying bone tissue structures and their responses to various external factors.

Latest Patents

Tianyang Liu holds a patent for a "Method and apparatus for constructing microfluidic bone organoid-on-chip." This innovative method allows for continuous observation of the impacts of different external factors on bone tissue structures. The approach is based on the 'ternary regulation theory' of bone angiogenesis, bone resorption, and osteogenesis coupling. The patent outlines a three-step process: building a visual three-dimensional cell cultivation platform, designing microfluidic channels to create concentration gradient distributions, and adding bioinks that include osteoblasts, osteoclasts, and vascular endothelial cells.

Career Highlights

Tianyang Liu is affiliated with the China-Japan Friendship Hospital, specifically within the China-Japan Friendship Clinical Medical Research Institute. His work at this institution has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in tissue engineering and regenerative medicine.

Collaborations

Tianyang Liu has worked alongside notable colleagues, including Fuqiang Gao and Weiguo Wang. Their collaborative efforts have further advanced the research and application of microfluidic technologies in biomedical fields.

Conclusion

Tianyang Liu's innovative work in microfluidic bone organoid technology represents a significant advancement in the study of bone tissue structures. His contributions are paving the way for future research and applications in regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…